fibromyalgia Clinical Trials and Research
Also known as: fibro, chronic widespread pain, fibromyalgia syndrome, fms, generalized musculoskeletal pain · ICD-10: M79.7
Fibromyalgia is a chronic condition causing widespread pain, fatigue, and other symptoms that significantly impact daily life. Clinical trial research aims to understand its causes, improve diagnosis, and develop more effective treatments to manage symptoms and improve quality of life. Find a Trial helps patients search for active studies.
Common questions about fibromyalgia clinical trials
What are clinical trials for fibromyalgia?
Clinical trials for fibromyalgia are research studies investigating new ways to prevent, detect, or treat the condition. These studies evaluate potential therapies, diagnostic tools, or symptom management strategies to improve patient care, drawing data from sources like ClinicalTrials.gov.
Who can participate in fibromyalgia clinical trials?
Eligibility criteria vary for each study, based on factors like age, symptom severity, and overall health. Researchers carefully define who can participate to ensure safety and gather meaningful data, as seen in studies listed on ClinicalTrials.gov. Patients should review specific criteria for each trial.
What are the different phases of clinical trials for fibromyalgia?
Fibromyalgia clinical trials typically progress through phases: Phase 1 assesses safety, Phase 2 evaluates effectiveness and side effects, Phase 3 compares new treatments to existing ones, and Phase 4 monitors long-term effects. This structured approach helps ensure thorough evaluation, as detailed on ClinicalTrials.gov.
Do clinical trials for fibromyalgia cost money?
Generally, participants do not pay to be in a clinical trial. Study sponsors usually cover research-related costs, and sometimes provide compensation for time and travel. Patients should always clarify financial arrangements with the study team, information often found on ClinicalTrials.gov.
What types of treatments are being studied in fibromyalgia clinical trials?
Research is exploring various approaches, including new medications targeting pain pathways, non-pharmacological interventions like exercise and cognitive behavioral therapy, and novel devices. These studies aim to find more effective ways to manage fibromyalgia symptoms, according to data from ClinicalTrials.gov and NIH RePORTER.
What are researchers learning about the causes of fibromyalgia?
Researchers are investigating potential causes such as central nervous system dysfunction, genetic predispositions, immune system involvement, and environmental triggers. Studies aim to better understand the underlying mechanisms to develop targeted treatments, as evidenced by research on NIH RePORTER and ClinicalTrials.gov.
Are there specific biomarkers being studied in fibromyalgia research?
Yes, researchers are actively looking for biomarkers that could help diagnose fibromyalgia or predict treatment response. This includes studying genetic markers, inflammatory markers, and brain imaging patterns to objectively identify the condition, according to studies on NIH RePORTER and ClinicalTrials.gov.
What might exclude someone from a fibromyalgia clinical trial?
Common exclusion criteria might include other chronic pain conditions, certain psychiatric disorders, pregnancy, or specific medical conditions that could interfere with the study or pose safety risks. These criteria ensure participant safety and study integrity, as outlined in protocols on ClinicalTrials.gov.
How to find a fibromyalgia trial that fits you
- Describe your fibromyalgia situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all fibromyalgia trials →